Transparency and reporting characteristics of COVID-19 randomized controlled trials

Transparency and reporting characteristics of COVID-19 randomized controlled trials

Abstract Background In the context of the COVID-19 pandemic, randomized controlled trials (RCTs) are essential to support clinical decision-making. We aimed (1) to assess and compare the reporting characteristics of RCTs between preprints and peer-reviewed publications and (2) to assess whether repo...

Full description

Bibliographic Details
Main Authors: Philipp Kapp, Laura Esmail, Lina Ghosn, Philippe Ravaud, Isabelle Boutron
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Medicine
Subjects:
COVID-19
Randomized controlled trial
Selective outcome reporting
Selection bias
Quality of reporting
Peer review; Completeness of reporting
Online Access:https://doi.org/10.1186/s12916-022-02567-y

Internet

https://doi.org/10.1186/s12916-022-02567-y

Similar Items